Clinical Trial

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Study acronym: ELEPHAS-05
Recruiting
View on ClinicalTrials.gov →
Summary
This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-02.
Trial Details
NCT Number NCT07327489
Lead Sponsor Elephas
Conditions Cancer, Immunotherapy, Advanced Solid Tumors Cancer, Bladder Cancer, TNBC, Triple Negative Breast Cancer, Colorectal Cancer, DMMR Colorectal Cancer, MSI-H Colorectal Cancer +7 more
Enrollment 2,000 participants
Start Date 2025-04-14
Primary Completion 2035-04 (estimated)
Study Completion 2038-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-29